Psychoactive Drugs: How Substances Change Brain Communication

Psychoactive Drugs and Consciousness

Caffeine, alcohol, nicotine, cannabis, prescription stimulants, opioids, LSD. These substances can produce very different effects. One may make you feel more alert. Another can slow your reaction time.

One may reduce pain. Another may alter your perception of time, color, or even your own thoughts. But here is what they have in common. They do not enter the brain and create an entirely new system.

They interfere with communication systems that were already there. Some copy the brain's chemical messengers. Some block them. Some stop the brain from clearing those messages away and others cause the system to release far more than it normally would.

So how can one chemical change the way a person thinks, feels, moves, remembers or experiences reality. To understand that, we need to return to a place we have visited before, the space between two neurons. Welcome back to The Psychology Notebook. This is our final lesson in module 3 on consciousness.

We began by asking what consciousness actually is. Then we explored how it changes during sleep, how attention can narrow during hypnosis, and how awareness can be trained through meditation. Each of those lessons showed us something important. Consciousness is not one fixed setting.

It changes as the brain shifts between different patterns of activity. Psychoactive drugs create another kind of shift. A psychoactive drug is a substance that changes brain activity in a way that can affect awareness, mood, perception, thinking, or behavior. The word psychoactive does not automatically mean illegal.

Caffeine is psychoactive. Alcohol is psychoactive. Nicotine is psychoactive. Many prescription medications are psychoactive.

What matters is not whether a substance is legal, illegal, prescribed, or purchased in a store. The term tells us that it can change how the brain and mind are functioning. This lesson is not about telling you which drugs are good or bad. It is also not about reducing every substance to one dramatic image or a frightening outcome.

We are going to look at what these substances do inside the nervous system. We will examine stimulants, depressants, opioids, cannabis, and psychedelics. Then we will look at what happens when the brain begins adapting to repeated exposure including tolerance, dependence, withdrawal, and addiction. Because before we can understand the risks, we first need to understand the mechanism.

Returning to the Synapse

Back in lesson six, we learned that neurons communicate using electrical and chemical signals. An electrical signal travels down the axon of the sending neuron. When it reaches the end, chemical messengers called neurotransmitters are released. Those neurotransmitters cross a tiny gap called the synapse.

Then they attach to the receptors on the receiving neuron. You can think of the neurotransmitter as a key and the receptor as a lock. But the key does not always stay in the lock forever. Once the message has been delivered, the brain needs a way to clear the signal.

Some neurotransmitters are broken down by enzymes. Others are pulled back into the sending neuron through a process called reuptake. This allows the system to reset before the next message arrives. When everything is working normally, the signal is released, received, cleared, and repeated.

But a psychoactive drug can interrupt that process at several different points.

Agonists: Activating Receptors

The first method is to imitate one of the brain's natural messengers. A substance that activates a receptor and produces a response is called an agonist. It acts like a copied key.

The substance may not be identical to the brain's natural neurotransmitter, but its shape allows it to activate the receptor. Nicotine, for example, can activate certain receptors normally used by acetylcholine. Opioid drugs can activate receptors used by the brain's natural opioid chemicals and THC can activate receptors that belong to the endocannabinoid system. Different keys, different locks, different effects.

Antagonists: Blocking Receptors

The second method is to block the receptor. A substance that prevents or reduces the usual receptor activity is called an antagonist. Instead of copying the key, it covers the lock. The normal messengers may still arrive, but it cannot activate the receptor in the usual way.

Caffeine works this way with adenosine. Adenosine is involved in the feeling of sleep pressure that builds throughout the day. Caffeine blocks adenosine receptors, making it hard for that tiredness signal to be received. It does not remove the body's need for sleep.

It temporarily hides part of the message.

Changing Reuptake and Release

The third method is to interfere with reuptake. Remember, reuptake is one of the ways the brain clears neurotransmitters from the synapse. When the cleanup system is blocked, more of the neurotransmitter remain in the gap.

The message continues for longer than it normally could. Cocaine, for example, interferes with transporter systems that help clear dopamine and other neurotransmitters. The brain has not necessarily produced an entirely new message. The old message is simply not being cleared normally.

Instead of preventing the cleanup crew from working, some substances cause the station to release unusually large amounts of its chemical messengers. Amphetamine type stimulants can increase signaling involving dopamine and norepinephrine. MDMA produces especially strong changes in serotonin signaling while also affecting other chemical systems. The exact mechanism is different from one substance to another, but the larger idea is still the same.

The normal balance of release, reception, and cleanup has been altered. And these mechanisms are not always separate. One substance may interact with several neurotransmitters, receptors, and brain regions at the same time. That is why a simple chart can help us remember the major systems, but it cannot tell the entire story.

Stimulants

Let's begin with the substances many people encounter every day. The stimulants, they do not simply give the brain more energy. They change how the brain receives and responds to signals involving alertness, attention, motivation, and reward. The first stop inside our brain communication center is the alertness station.

This is where signals related to attention, wakefulness, motivation, movement, and readiness for action are being coordinated. Substances that increase certain forms of activity in the central nervous system are called stimulants. But that does not mean every stimulant works by pressing one universal speed up button. Caffeine blocks a tiredness signal.

Nicotine imitates a natural messenger. Cocaine interferes with the brain's cleanup system. Amphetamine type stimulants can increase the release of certain neurotransmitters. They may belong to the same broad category, but they enter the system through different doors.

Caffeine

Let's begin with one of the most widely used psychoactive substances in the world, caffeine. And to understand caffeine, we need to bring back someone from our sleep lesson. Adi adenosine. Throughout the day, adenosine activity contributes to the pressure to sleep.

And that signal builds. As that signal builds, the brain becomes more aware that the body has been awake for a long time. Caffeine has a shape that allows it to occupy adenosine receptors without activating them in the normal way. In other words, caffeine blocks the lock.

Addie may still be carrying the tiredness message, but the receptor is temporarily unavailable. That can reduce the feeling of sleepiness and make someone feel more alert. But notice what caffeine did not do. It did not remove the adenosine.

It did not replace lost sleep and it did not create new energy. It made it harder for the part of the tiredness signal to be received. The sleep pressure may still be building behind the blocked receptor. The FDA identifies caffeine as an inhibitor at major adenosine receptor types including A1 and A2A receptors.

This also explains why caffeine can make someone feel more awake without making the brain fully rested. Alertness and restoration are not the same thing.

Nicotine

Now let's move to nicotine. Nicotine uses a different mechanism.

It resembles acetylcholine closely enough to activate a group of receptors called nicotinic acetylcholine receptors. So instead of blocking the lock, nicotine uses a copied key. Acetylcholine is involved in many functions including attention, learning, arousal, and muscle activity. When nicotine activates these receptors, it can influence several other systems throughout the brain and body. that includes pathways involving dopamine which can strengthen learning around the experience and contribute to continued use.

This is an important reminder that the textbook chart shows us the primary doorway. Nicotine enters through acetylcholine receptors, but its effects do not stop with acetylcholine. Nicotinic acetylcholine receptors are an established target in nicotine research and nicotine's effects also involve reward related dopamine signaling. That pattern will repeat throughout this lesson.

We may name one major neurotransmitter to help organize the information. But psychoactive substances rarely affect only on one chemical, one receptor, and one area of the brain. The brain is a network. When one station changes, other stations respond.

Cocaine and Dopamine

Next, we arrive at the dopamine station. Dopamine is often called the brain's pleasure chemical, but that description is much too limited. Dopamine helps the brain learn what matters. It is involved in motivation, movement, attention, reinforcement, and the drive to repeat behaviors connected to important outcomes.

Normally, after dopamine is released into the synapse, transporter proteins help collect it and carry it back into the sending neuron. Cocaine interferes with those transporters. the cleanup system becomes blocked. Dopamine remains available in the synapse longer than it normally would, continuing to activate receptors. Cocaine also affects transporters for other neurotransmitters, including norepinephrine and serotonin.

But its effects on dopamine signaling is especially important for understanding reinforcement and repeated use. Cocaine's major influence on dopamine signaling is blocking the transporter that normally clears dopamine from the synaptic space which prolongs receptor activity.

Amphetamine-Type Stimulants

Amphetamine type stimulants affect the station differently. Instead of only blocking the cleanup system, they can also cause more dopamine and norepinephrine to be released into the space between neurons.

Methamphetamine can produce especially large changes in these signaling systems. So while cocaine largely keeps released dopamine from being cleared normally, amphetamine type drugs can increase the amount being released while also disrupting normal transport. The final picture may look similar with more neurotransmitter activity in the synapse, but the path that created it is different. Government clinical guidance distinguishes these mechanisms.

Cocaine mainly blocks transporter mediated clearance while amphetamine type stimulants can also increase neurotransmitter release. This distinction is worth writing down. Two substances can increase activity in the same neurotransmitter system without working in exactly the same way. The outcome does not tell you the entire mechanism.

Prescription Stimulants

At this point, you may be wondering about prescription stimulants. How can something classified as a stimulant help a person who has difficulty controlling attention, activity, or impulses? The answer is not that the medication simply makes everyone more stimulated. These medications increase activity involving dopamine and norepinephrine and brain networks connected to attention, executive functioning, and impulse control.

When the medication is properly prescribed and monitored, the goal is to support more regulated communication in those networks. Methylphenidate primarily slows the reuptake of dopamine and norepinephrine. Amphetamine medications also affect the release of these neurotransmitters. The substance amount, timing, formulation, and person's underlying condition all matter.

Taking a medication as prescribed is not the same situation as misusing it. Taking someone else's prescription or using it in a way intended to produce intoxication. So stimulants do not all use the same method. Caffeine blocks adenosine receptors.

Nicotine activates acetylcholine receptors and influences additional systems. Cocaine blocks the normal clearance of dopamine and other neurotransmitters. Amphetamine type stimulants increase release and disrupt normal transport. Prescription stimulants use some of the same chemical pathways, but therapeutic use takes place within a controlled treatment plan.

The category tells us the general direction of the effect. The mechanism tells us how the change happens. But consciousness can also change in the opposite direction. Instead of increasing alertness and activity, some substances strengthen inhibitory signals or weaken excitatory ones.

Reaction time slows, coordination changes, judgment becomes less reliable, and sometimes the first behavior to become less controlled is the person's ability to recognize how impaired they already are.

Depressants and Alcohol

The next room inside our brain's communication center controls something just as important as activity. It controls restraint. Neural communication is a constant balance between signals that make activity more likely and signals that make activity less likely.

Substances that slow or reduce certain forms of central nervous system activity are called depressants, but that name can be misleading. A depressant does not necessarily make someone feel emotionally depressed. The term refers to what the substance does to activity in the nervous system. And one of the most familiar examples is alcohol.

Alcohol is more complicated than the simple chart might suggest. It does not affect only one neurotransmitter. Instead, it changes communication across several brain systems. Two of the most important for this lesson are GABA and glutamate.

GABA is the brain's major inhibitory neurotransmitter. You can think of GABA as part of the braking system. When GABA delivers its message, it makes the receiving neuron less likely to fire. Glutamate is the brain's major excitatory neurotransmitter.

It often acts more like an accelerator, making neural activity more likely. Alcohol generally increases inhibitory effects while reducing some excitatory activity. The brake becomes stronger. the accelerator becomes less responsive. That combination helps explain why reaction time, coordination, speech, memory, and judgment can become impaired.

Alcohol also affects reward circuits involving dopamine and other signaling systems. So, GABA alone does not explain its effects. But this creates an interesting question. If alcohol is a depressant, why can someone initially seem louder, more excited, or more social?

Because the brain does not slow down everywhere at exactly the same time. Some of the first abilities to become weaker involve judgment, restraint, and impulse control. The brain's internal editor becomes less effective. A person may talk more, take greater risks, or feel unusually confident.

This can look like stimulation, but the nervous system is not becoming more controlled or more accurate. The systems that normally hold behavior back are becoming less effective. As alcohol's effects increase, slower reaction time, poor coordination, slurred speech, and difficulty maintaining balance become more visible. This distinction is worth writing down.

Alcohol does not create better social skills or clearer confidence. It weakens some of the systems that normally monitor and restrain behavior.

Alcohol and Memory

Alcohol can also disrupt the brain's ability to form new memories. The hippocampus helps stabilize new information so it can be stored and remembered later.

At high levels of intoxication, a person may remain aware, speak, move, and interact with other people while the hippocampus fails to properly consolidate parts of that experience. This is the alcohol-related blackout. A blackout is not the same as passing out. When someone passes out, they lose consciousness.

During a blackout, the person may still be conscious, but portions of the experience are not being transferred into lasting memory. The memories are not simply hidden. It's a complete blackout. Some of them may never have been formed in the first place.

Benzodiazepines and Combined Depressant Effects

Alcohol is not the only substance classified as a depressant. Some medications are designed to reduce excessive nervous system activity. Benzodiazepines, for example, may be prescribed for conditions such as anxiety, insomnia, or seizures. They increase the effect of GABA at a specific type of receptor, helping reduce neural excitability.

When prescribed and monitored appropriately, these medications can have legitimate medical uses, but they can also produce sedation, physical dependence, and withdrawal. Abruptly stopping a benzodiazepine after the body has adapted can be dangerous, which is why discontinuation should be managed with a health care professional. The FDA requires boxed warnings describing risks that include misuse, addiction, physical dependence, and potentially serious withdrawal reactions. One of the most important safety principles in this lesson is that depressants do not reliably balance one another.

Their effects can combine. Alcohol, benzodiazepines, and opioids influence the nervous system through different receptor systems, but all can suppress activity involved in essential functions. When they are combined, the danger is not limited to feeling unusually sleepy. Breathing can become dangerously slow or stop.

The effects may be stronger than someone expects because the substances can amplify one another rather than merely adding together. Federal health guidance warns that combining alcohol with benzodiazepines or opioids can increase the risk of severe respiratory depression, overdose, coma, and even death. So, alcohol is called a depressant because it reduces certain forms of nervous system activity. It strengthens inhibitory effects, weakens some excitatory signaling, and changes communication in reward, memory, movement, and judgment networks.

This explains why someone can initially appear excited while their restraint and decision-making are already becoming less reliable. It also explains why alcohol can disrupt memory and why combining it with other sedating substances can become especially dangerous. The simple category tells us the general direction. The brain networks explain the actual experience.

But not every psychoactive drug fits neatly into the stimulant or depressant categories. Some may produce relaxation in one person, anxiety in another, and changes in memory, time, appetite, or perception. To understand the next substance, we need to enter a system that does not simply press the accelerator or the brake. It fine-tunes communication through the brain.

The endocannabinoid system.

Cannabis and the Endocannabinoid System

The name endocannabinoid system may make it sound as though the system exists because of cannabis. It does not. Your brain and body naturally produce their own cannabinoid-like chemical messengers called endocannabinoids.

Two of the best known are anandamide and 2-AG. These messengers can help fine-tune communication related to processes such as memory, stress, appetite, pain, movement, and reward. And they communicate in a particularly interesting way. Most neurotransmitters travel from the sending neuron to the receiving neuron.

Endocanabonoids can travel in the opposite direction. The receiving neuron releases a feedback message that moves backward across the synapse and attaches to CB1 receptors on the sending neuron. The receiving neuron releases a feedback message that moves backward across the synapse and attaches to the CB1 receptors on the sending neuron. That message essentially says adjust how much neurotransmitter you are releasing.

So this is not simply an accelerator or a brake. It's more like a network of small adjustment dials that help keeps communication regulated. This unusual direction is worth writing down. The endocannabinoid system helps regulate other neurotransmitter systems by adjusting how much chemical signaling is released.

Cannabis contains many active chemical compounds called cannabinoids. The compound responsible for most of cannabis's intoxicating and mind-altering effects is tetrahydrocannabinol, usually shortened to THC. THC resembles the brain's natural endocannabinoid messengers closely enough to activate cannabinoid receptors, especially CB1 receptors in the brain. So THC acts like another copied key.

But the brain's natural endocannabinoid signals are normally produced when and where they are needed. They are part of the carefully timed feedback system. THC enters from outside that system and activates cannabinoid receptors across multiple brain networks. The result is a broader disruption of the brain's normal adjustments.

This can alter memory, attention, coordination, movement, emotion, decision-making, reaction time, and the perception of time. Where cannabinoid receptors are located helps explain many of these effects. CB1 receptors are abundant in the hippocampus, which plays an important role in forming new memories. When THC disrupts signaling there, holding on to new information become more difficult.

CB1 receptors are also found in brain systems involved in movement and coordination, including the cerebellum and the basal ganglia. This helps explain why reaction time, balance, precision, and coordination can change. Cannabonoid receptors are also spread through areas of the cerebral cortex that help integrate attention, perception, judgment, and higher level thinking. So, the effects are not coming from one isolated cannabis center.

They emerge because the brain's regulation network reaches many different systems at once. This is also why feeling capable of driving is not the same as being unimpaired. Driving requires attention, coordination, judgment, accurate perception, and rapid decision-making. Cannabis can interfere with all of these abilities, and combining cannabis with alcohol may increase impairment further.

Cannabis does not produce exactly the same experience in every person or situation. One person may report relaxation. Another may experience anxiety, disorientation, panic, or paranoia. The effects can change based on the amount of THC, the concentration of the product, previous experience, age, individual biology, expectations, the surrounding environment, and whether other substances are present.

This is another example of why a drug's name alone cannot predict the entire experience. The substance matters, the person matters, and the situation matters. It is also important not to treat every cannabinoid as though it produces the same effect. THC is intoxicating and mind-altering.

Cannabidiol or CBD does not produce the same intoxicating effect. But not intoxicating does not mean that every CBD product is proven safe, accurately labeled, or free from interactions. There are approved cannabinoid-based medications for specific medical conditions. But a standardized medication is not the same thing as every product sold with a cannabis or a CBD label.

So cannabis does not simply press the accelerator or strengthen the brake. THC enters a feedback system that normally fine-tunes communication through the brain. By activating cannabinoid receptors, it can change how memory, coordination, attention, emotion, and time, perception are regulated. That is why cannabis does not fit perfectly into only one traditional drug category.

Its effects can overlap with depressants, stimulants, and hallucinogens depending on the person, the substance, and the situation. The next substances also use copied keys, but instead of entering a system that fine-tunes memory, movement, and attention, they activate receptors involved in pain relief, reward, stress, and survival. The brain already produces its own opioid chemicals. But when powerful external substances activate those receptors, pain may decrease while another essential function begins slowing down.

Opioids

Before opioid drugs existed, your brain already had an opioid system. The body produces its own opioid-like chemical messengers including endorphins and enkephalins and dynorphins. These natural messengers attach to opioid receptors in the brain, spinal cord, and other parts of the body. They help regulate pain, stress, reward, and emotional responses.

You can think of the endogenous opioid system as part of the brain's built-in pain management network. When the body is injured or under intense stress, natural opioid signaling can reduce how strongly pain signals are experienced. But these chemicals do not simply erase every pain signal. They adjust how pain information is transmitted and interpreted.

You may also hear the words opioid and opiate used as though they mean exactly the same thing. An opioid is a broader category. It includes naturally derived substances, partly synthetic substances, and fully synthetic substances that act on opioid receptors. For this lesson, we will use the broader term opioids.

Opioid drugs enter this natural system by activating opioid receptors. Once again, we are seeing an agonist. A copied key enters a lock that the brain already uses. There are several types of opioid receptors, but the mu opioid receptor is essentially important for understanding pain relief, reward, sedation, and slowed breathing.

Prescription pain medication such as morphine and oxycodone act on opioid receptors. Heroin and synthetic opioids such as fentanyl enter the same broad receptor system. The brain does not label one key medicine and another illegal drug. It responds to the chemical interaction taking place at the receptor.

The context still matters greatly. A medication taken as prescribed and monitored for pain is not the same behavior as misusing a medication or using an unregulated substance. But the underlying receptor system is related. When opioid receptors are activated along pain pathways, the transmission and experience of pain can decrease.

That is why opioids can have an important medical role in certain situations. But opioid receptors are also connected to circuits involved in motivation, reinforcement, and reward. When a substance produces powerful relief, the brain can learn that the substance is important. And relief itself can be reinforcing.

A person does not always continue using a substance simply to pursue pleasure. They may be trying to escape pain, distress, withdrawal, or the return of an uncomfortable internal state. This is the one reason addiction cannot be explained by the phrase they just wanted to feel good. The learning system is responding to both rewards and relief.

This distinction is worth writing down. Negative reinforcement does not mean punishment. It means that a behavior becomes stronger because something unpleasant is removed or reduced. The same receptor system that reduces pain can also affect brainstem where essential automatic processes are regulated.

One of those processes is breathing. Normally brainstem networks continually monitor the body and maintain the rhythm that keeps air moving in and out of the lungs. When opioid activity becomes too strong, the brain's drive to breathe can become dangerously weak. Breathing may become slow, shallow, irregular, or stop entirely.

Naloxone and Emergency Care

An opioid overdose can sometimes be reversed with a medication called naloxone. Naloxone is an opioid antagonist. Instead of activating the opioid receptor, it attaches to the receptor and blocks opioid effect. If it is given in time, naloxone can restore breathing that has slowed or stopped because of an opioid overdose.

But naloxone is temporary. The person still needs emergency medical care. If an opioid overdose is suspected, administer naloxone if it is available. Call 911.

Try to keep the person breathing. Place them on their side to reduce choking risk and stay with them until emergency help arrive. With repeated opioid exposure, the brain may begin adjusting to the substance continued presence. Receptors and neurocircuits can become less responsive.

The same amount may no longer produce the same effect. This is called tolerance. The body may also begin functioning as though the substance is part of its expected chemical environment. If use suddenly stops, the nervous system may swing in the opposite direction, producing withdrawal symptoms.

This is physical dependence. Tolerance and dependence can develop during ongoing medical treatment. Neither one automatically proves that a person has an addiction. We will separate these concepts more carefully later in the lesson.

So, opioids enter a system the brain already uses to regulate pain, stress, and reward. They activate opioid receptors and can reduce the experience of pain. But those receptors are also connected to reinforcement, sedation in the brain's control of breathing. The same copied key that reduces pain can become dangerous when receptor activity grows strong enough to suppress respiration and naloxone works because it block the lock.

Opioids change consciousness partly by quieting brain and slowing activity. But the next group can change the way the brain organizes perception itself. Colors may appear different. Time may feel distorted.

Ordinary objects may take on unusual meaning. And the boundary between an internal thought and an external perception may become less reliable. To understand why, we need to return to serotonin. But this time, we are not entering the mood station.

We are entering the brain's interpretation room.

Psychedelics and Perception

Every second your brain receives an enormous amount of information. Light reaches the eyes. Sound reaches the ears.

Signals arrive from the body. Memories, expectations, and emotions add meaning to what you are experiencing. But perception is not a perfect recording of the outside world. The brain selects information, organizes it, compares it with previous experience, and constructs an interpretation.

Classical psychedelics can temporarily alter that process. They may change how sensory information is organized, how attention moves, how time is experienced, and how much meaning a person attaches to an ordinary thought or object. So, psychedelics do not simply add strange pictures to an otherwise normal mind. They can change the way the brain constructs the experience itself.

Psychedelic drugs can temporarily produce major changes in mood, thought, perception, and a person's sense of reality. To understand classical psychedelics such as LSD and psilocybin, we need to return to serotonin. Serotonin is often described as a mood chemical. But serotonin is involved in much more than mood.

It influences sleep, appetite, attention, learning, emotional processing, and the way information moves through different brain network. And serotonin does not use only one type of receptor. There are many serotonin receptor families and each can produce a different response. Classical psychedelics interact with several receptors, but one is especially important.

The 5-HT2A receptor LSD and psilocin, the active form produced from psilocybin, act as agonist at 5-HT2A receptors. These receptors are especially common in areas of the cerebral cortex involved in integrating perception, thought, and meaning. These receptors are especially common in areas of the cerebral cortex involved in integrating perception, thought, and meaning. This distinction is worth writing down.

Classical psychedelics do not add more serotonin to the synapse. Their defining mechanism involves activating particular serotonin receptors, especially 5-HT2A. Activating these receptors changes the activity of cortical neurons in the way larger brain network communicate. Systems that normally maintain relatively stable boundaries may begin sharing information in less typical ways.

Visual signals may interact more strongly with emotion or memory. Thoughts may feel unusually vivid or important. Time may seem to move slowly, rapidly, or lose its usual structure. A person may notice patterns that ordinarily would have been ignored.

They may also misinterpret ambiguous information or have difficulty separating an internal association from what is actually happening around them. Researchers are still studying exactly how these receptor level changes produce full experience, but evidence strongly support 5-HT2A receptor activation as central to the acute psychedelic effect of LSD, psilocybin, and other classical psychedelic. The word hallucinogen can also create a misleading picture. People sometimes imagine that psychedelic use always means seeing completely formed people or objects that are not present.

That can occur, but many reported effects are better described as perceptual distortions. Colors may appear more intense. Stationary patterns may seem to move. Sounds may feel unusually layered.

The size or distance of an object may seem altered. Someone may experience vivid imagery while their eyes are closed. The larger category includes changes in perception, thought, emotion, and the sense of self, not just visual hallucinations. The experience also depends on more than the chemical alone.

Psychologists often use the term set and setting. Set refers to what the person brings internally, such as their expectations, their emotional state, their memories, their personality, and what they believe is about to happen. Setting refers to the physical and social environment. Is the person somewhere familiar or unfamiliar?

Do they feel secure or threatened? Are the people around them calm or unpredictable? Because psychedelics alter perception, emotion, and meaning-making, fear can feed into perception and confusing surroundings can become even more difficult to interpret. This helps explain why reported experiences can range from feelings of wonder or connection to intense anxiety, panic, or fear.

You may have also heard about psychedelics being studied as possible treatments for mental health conditions. That research takes place in controlled settings with carefully selected participants, standardized substances, preparation, professional supervision, and follow-up care. Clinical study is not the same situation as taking an unknown substance in an uncontrolled environment. Research into possible medical benefits does not mean that every substance, product, person, or setting is safe.

NIDA continues to support research examining whether certain psychedelic drugs may have therapeutic value when used within structured medical settings.

MDMA

MDMA is often placed beside hallucinogens, but it does not fit neatly into the classical psychedelic category. It is chemically related to amphetamines and produces stimulant-like effects. It can increase alertness, energy, heart rate, and body temperature.

It may also mildly alter visual or time perception. But one of its most recognizable effects involves changes in emotional openness, social connection, and sensitivity to other people. Because of this unusual combination, MDMA is sometimes described as an entactogen or an empathogen. That means a substance is associated with feelings of emotional closeness or interpersonal openness.

But that label describes the experience. To understand the mechanism, we need to look inside the serotonin station. MDMA strongly affects the transporters responsible for serotonin norepinephrine and dopamine. Its effects is especially pronounced in serotonin systems.

Normally the serotonin transporter helps carry serotonin out of the synapse and back into the sending neuron. MDMA enters through that transporter and disrupt the normal process. The transporter can begin moving serotonin in the opposite direction. Instead of collecting the messenger, the system releases more of it.

Serotonin signaling rises sharply in the synapse. MDMA also increases norepinephrine and dopamine signaling which helps explain its stimulant and reinforcing effect. So MDMA is not simply a serotonin agonist like a classical psychedelic. It changes neurotransmitter transport and release.

This is another distinction worth writing down. LSD primarily changes serotonin signaling by activating specific receptors. MDMA strongly changes the release and transport of serotonin itself. Both involve serotonin, but they do not use the same mechanism.

MDMA can also increase oxytocin levels. Oxytocin is involved in social bonding and social behavior which may contribute feelings of warmth and closeness. But it would be too simple to call MDMA an oxytocin drug. Its effects emerge from serotonin, norepinephrine, dopamine, hormones, expectations, and the social environment working together.

And feeling emotionally close to someone does not guarantee that trust, judgment, or the interpretation of another person's intentions become more accurate. Human studies have found that MDMA can increase circulating oxytocin, although oxytocin alone does not fully explain its psychological or social effect. So, classical psychedelics and MDMA both interact strongly with serotonin systems, but they are not interchangeable. LSD and psilocin primarily produce their defining psychedelic effect by activating serotonin receptors especially 5-HT2A.

MDMA strongly increases serotonin release and also affect norepinephrine dopamine hormones and social emotional processing. Classical psychedelics reorganize perception and meaning. MDMA combines stimulant effects with changes in mood, connection and mild perception. The neurotransmitter may be similar.

The mechanism and experience are different.

Neuroadaptation

We have now followed psychoactive substances through several different communication systems. Some block receptors, some copied natural messengers, some stopped reuptake, some increased release. But the brain is not passive.

When chemical signaling changes repeatedly, the nervous system begins responding to the change. Receptors adjust, circuits adapt. Learning strengthens associations, and the presence of the substance may gradually become part of the brain's expected environment. Next, we need to separate four terms that are often confused.

Tolerance, dependence, withdrawal, and addiction. The brain is constantly trying to maintain a workable internal balance. When neural activity rises, other systems may respond by turning it down. When a receptor is activated repeatedly, the receiving neuron may become less responsive.

When an outside chemical repeatedly changes neurotransmitter signaling, the brain may begin adjusting its own settings around that chemical. This process is called neuroadaptation. The brain is not deciding that it wants the substance. It is responding to a chemical environment that keeps repeating.

And once the system has adapted, the person's response may begin to change.

Tolerance

The first term is tolerance. Tolerance means that repeated exposure has produced a reduced response. The same amount of a substance may no longer create the same effect it once did or a greater amount may be needed to produce a similar effect.

Imagine that a substance repeatedly turns the volume of a neural signal far above its normal level. The brain may respond by lowering receptor sensitivity or adjusting other parts of the pathway. Now, when the same chemical signal returns, the system responds less strongly. But tolerance does not develop equally for every effect.

A person may become tolerant to one noticeable effect while remaining vulnerable to another dangerous effect. And tolerance can decrease after a period without the substance. Returning to an amount previously used can then carry a greater risk than the person expects. Tolerance is one possible feature of a substance use disorder, but it can also occur as a physiological adaptation during appropriately supervised prescription treatment.

Tolerance does not mean that a substance has become harmless. It means that the person's response to some of its effect has changed.

Physical Dependence

The second term is physical dependence. Dependence develops when the nervous system has adapted to the continued presence of a substance.

The brain has adapted its controls as though the substance is now part of the usual environment. When that substance remains present, the altered system may appear relatively stable. But when this substance is suddenly removed, the brain is left operating with all of those adaptations and none of the chemical effect they were designed to balance. The system may swing in the opposite direction.

A substance that repeatedly slowed neural activity may be followed by excessive activity when it disappears. A substance that repeatedly activated a system may be followed by unusual low activity. Physical dependence can occur with substances that are misused, but it can also develop while a medication is being taken exactly as prescribed. This is why dependence by itself does not prove that someone has an addiction.

Withdrawal

The symptoms that appear when an adapted nervous system no longer receives substance are called withdrawal. Withdrawal is not one universal experience. The symptoms, timing, and level of danger depend on the substance, the pattern of exposure, the person's health, and other factors. Withdrawal may involve changes in sleep, mood, pain, digestion, concentration, heart rate, nervous system activity, and other bodily functions.

With some substances, withdrawal is primarily uncomfortable. With others, it can become medically dangerous. Suddenly stopping heavy prolonged alcohol use can lead to seizures and other potentially life-threatening complications. Abruptly stopping benzodiazepines after dependence has developed can also cause severe reactions including seizures.

This is why people who may be physically dependent on alcohol, benzodiazepines, opioids and other medications should seek professional guidance rather than making abrupt changes alone. So far we have three related but different ideas. Tolerance describes a reduced response. Dependence describes body's adaptation.

Withdrawal describes what may happen when the adapted system no longer receives the substance. None of these terms alone tells us whether someone has lost control of their substance use. For that, we need to look at the larger pattern of behavior.

Substance Use Disorder and Addiction

In clinical psychology, the formal diagnosis is called substance use disorder or SUD.

A substance use disorder is not diagnosed simply because someone has used a substance. It is not diagnosed simply because someone developed tolerance and it is not and it is not diagnosed only by asking how frequently someone uses. Clinicians look for patterns in which substance use causes meaningful impairment, distress, risk, or loss of control. The diagnostic criteria include experiences such as using more than intended, repeatedly trying and struggling to reduce use, spending a substantial time obtaining, using or recovering from the substance, experiencing strong cravings, having difficulty fulfilling responsibilities, continuing despite relationship, psychological or physical problems, giving up important activities, using in hazardous situations, and continuing even while recognizing the harm.

Tolerance and withdrawal may also be included depending on the substance and circumstances under the DSM-5 framework used by SAMHSA. Meeting at least two criteria within a 12-month period may qualify as a substance use disorder. The severity depends on how many criteria are present. Tolerance and withdrawal that occur solely during appropriate medical treatment are not automatically counted as evidence of a prescription drug use disorder.

The word addiction is often used for the more severe end of substance use disorder. Its defining feature is not simply how often a person uses. It is the growing difficulty controlling the behavior despite serious consequences. Someone can use the substance frequently without meeting the criteria for addiction.

Someone else may use less visibly while experiencing intense cravings, repeated failed attempts to stop hazardous use, or major disruptions to their life. The pattern matters more than the stereotype. And addiction is not evidence that someone is selfish, weak, or morally defective. Repeated substance use can alter systems involved in learning, motivation, stress, judgment, and behavioral control.

At the same time, biology, environment, development, mental health, stress, relationships, and access to support can all influence risk and recovery. Effective treatment and long-term recovery are possible. This may be the most important distinction in the entire lesson. Physical dependence describes an adaptation of the body.

Addiction describes a larger pattern involving impaired control and continued use despite harm. They can occur together. They are not the same thing. But this leaves us with another question.

If two people encounter the same substance, why might one develop a serious problem while the other does not? There is no single addiction personality. There is no one gene, childhood experience or brain difference that determines the outcome. Risk develops through an interaction between the substance, the person and the environment.

To understand the interaction, we need to move beyond the synapse and look at the complete biopsychosocial picture.

The Biopsychosocial Picture

When we ask why some people develop substance related problems and others do not, it can be tempting to search for one simple cause. Maybe it's genetic, maybe it is stress, maybe it is the substance itself. But addiction does not have one universal starting point.

Risk develops through an interaction between biological vulnerability, psychological experience, the surrounding environment, and the properties of the substance. These factors do not work like a checklist where one item guarantees an outcome. They change probability. A risk factor makes a problem more likely.

A protective factor makes it less likely. Neither one determines a person's future. Risk and protective factors can operate across the individual, family, peer, school, community, and the broader social environment.

Biological Factors

Biological factors include genetics, age, metabolism, physical health, brain development, and individual differences in how strongly someone responds to a substance.

Genes can influence traits such as sensitivity to reward, impulsivity, stress reactivity, metabolism, and vulnerability to particular substance use disorders. But there is no single addiction gene. A person may inherit a greater or smaller vulnerability, not a predetermined outcome. Biology can also affect how a substance moves through the body.

The same amount may produce different effects depending on body composition, metabolism, medications, sleep, health conditions, and previous exposure. Genetic factors account for a substantial portion of addiction vulnerability, but environment and life experience remained essential parts of the picture.

Psychological Factors

Psychological factors include learning, expectations, coping skills, emotional distress, trauma, mental health, and the meaning a person associates with the substance. A substance may become connected to a specific outcome.

Relief from anxiety, escape from painful memories, confidence in social situations, energy during exhaustion, sleep after a stressful day. Each time the substance appears to solve an immediate problem, the brain may strengthen that association. This does not mean that every person who experiences stress, trauma, anxiety, or depression will develop a substance use disorder. It means that substances can become part of a learned coping pattern, especially when healthier or safer forms of support are difficult to access.

Substance use disorders are influenced by learning, stress, mental health, and changes in systems involved in judgment, memory, motivation, and behavioral control. This is worth writing down. A behavior can become strongly learned even when it creates serious long-term harm, especially if it produces immediate relief.

Social and Environmental Factors

The social environment also shapes risk.

Availability matters. Family and peer behavior matter. Stressful living conditions matter. Culture, advertising, community resources, financial pressure, discrimination, social isolation, and access to health care can influence pathways available to a person.

If substance use is consistently connected with belonging, celebration, coping, or acceptance, those social rewards can strengthen the behavior. If treatment is expensive, unavailable, difficult to reach, or heavily stigmatized, asking for help becomes harder. But the environment can also protect people. Supportive relationship, clear expectations, stable housing, meaningful activities, access to health care, and having someone trustworthy to speak with can all help reduce risk and support recovery.

Research on prevention treats risk and protection as operating across families, peers, schools, communities, and society rather than existing only inside the individual. Research on prevention treats risk and protection as operating across families, peers, communities, and society rather than existing only inside the individual.

Age and Development

Age and development also matter. The adolescent brain is still reorganizing systems involved in planning, judgment, emotional regulation, reward, and impulse control.

At the same time, learning from rewards and social experiences can be especially powerful. This does not mean that teenagers are incapable of making good decisions. It means that repeated substance exposure is occurring while important neural systems are still developing. Earlier initiation is associated with a greater risk of later substance related problems.

Although early use does not guarantee that a disorder will develop. Alcohol research, for example, links adolescent heavy drinking with disruption of brain development and a greater risk of alcohol use disorder later in life.

Recovery

The same ability of the brain to adapt can also support recovery. Neural pathways are not frozen.

New routines can be learned. Triggers can become more manageable. Stress can be treated. Relationships can be repaired or replaced with healthier support.

And medications, counseling, behavioral treatments, peer support, and changes in the environment can all become part of recovery. Recovery does not always follow one straight line. A return to use does not erase every change a person has made, but it may signal that a treatment plan or level of support needs change. The brain's plasticity contributes to addiction, but it also allows healthier patterns to strengthen over time.

Evidence from alcohol research indicates that at least some brain and behavioral changes can improve during sustained recovery. So vulnerability is not located in one gene, one choice, one family or one difficult experience. It emerges from interacting systems. The biology of the person, their psychological experiences, their social environment, the properties of the substance and the stage of development during which those factors meet.

But there is one more reason that drug effects can become difficult to predict. The brain does not always encounter one substance at a time. Alcohol may be combined with a medication. A stimulant may be taken alongside a depressant.

A pill may contain a substance the person did not know was there. And when several chemicals enter the communication center together, their effects do not simply cancel one another out. Next, we need to look at polysubstance use and why mixing drugs can make the outcome more dangerous and less predictable.

Polysubstance Use

Polysubstance use means that a person is exposed to more than one drug within the same general period.

Sometimes that exposure is intentional. A person may combine substances because they expect one to strengthen, extend, or reduce the effects of another. But polysubstance use exposure can also be unintentional. Someone may combine alcohol with a medication without recognizing the interaction.

A counterfeit pill may contain a different substance than the person expected. Or an illegal drug may have been mixed with an opioid such as illegally manufactured fentanyl. In every case, the brain communication center is now responding to several chemical changes at once, and the result can be stronger, less predictable, and more dangerous than the effect of either substance alone. A common misconception is that a stimulant and a depressant will balance each other out.

One moves activity up, the other moves activity down. So perhaps they should cancel out, but the nervous system is not one volume dial. A stimulant may increase heart rate, blood pressure, alertness, and physical activity. At the same time, a depressant may slow reaction time, weaken coordination, impaired judgment, or suppress breathing.

Both sets of effects can happen at once. The stimulant may also mask some of the sleepiness produced by the depressant. The person may feel more awake and assume they are less impaired, but the depressant has not disappeared. Feeling one effect less clearly does not mean that the danger has been removed.

The CDC warns that the stimulants and depressants do not cancel one another and may instead mask or unpredictably modify each other's effects. This distinction is worth writing down. Masked impairment is still impairment. A person may feel more awake without becoming more coordinated, more accurate, or medically safer.

Combining substances that all suppress nervous system activity can be especially dangerous. Alcohol, benzodiazepines, and opioids do not use exactly the same receptors, but each can contribute to sedation and reduce nervous system activity. Opioids can weaken the brain drive to breathe. Alcohol and benzodiazepines can add further suppression.

Together these effects can produce profound sedation, loss of consciousness, respiratory failure, coma, or death. This is not one substance neutralizing another. It is several chemical pathways placing pressure on the same essential function. Unintentional polysubstance exposure has become especially important because an unregulated pill or powder may not contain what its appearance suggests.

Illegally manufactured fentanyl can be mixed into other drugs or presented into counterfeit tablets made to resemble legitimate prescription medication. A person may believe they are encountering one type of substance while unknowingly being exposed to a powerful opioid and appearance alone cannot reliably reveal what is inside. This creates a psychological problem as well as a chemical one. The person makes a decision based on the effect they expect, but the brain and body respond to the chemicals that are actually present.

So polysubstance use is not dangerous because the brain becomes confused by two category labels. It is dangerous because several real physiological effects are occurring at the same time. One substance may mask another. Two depressants may strengthen the suppression of breathing.

A stimulant in an opioid may strain different systems simultaneously. And an unknown substance may introduce an effect the person never anticipated. The more systems that change at once, the harder the outcome becomes to predict.

Lesson Recap

We began this lesson with one central question.

How can a chemical change the way someone thinks, feels, moves, remembers, or experiences reality. The answer is that psychoactive drugs interact with communication systems the brain already uses. Caffeine blocks adenosine receptors, making part of the tiredness message harder to receive. Nicotine activates receptors normally used by acetylcholine.

Cocaine interferes with the transporters that normally clear dopamine and other neurotransmitters. Amphetamine type stimulants, increase neurotransmitter release and disrupt normal transport. Alcohol strengthens some inhibitory effects, weakens some excitatory signaling, and alters several connected brain systems. THC activates receptors in the brain's natural endocannabinoid regulation network.

Opioids activate receptors involved in pain relief, reward, and breathing. Classical psychedelics alter perception and meaning partly by activating serotonin. An MDMA strongly changes serotonin release and transport while also affecting norepinephrine, dopamine, hormones and social emotional processing. Different substances, different receptors, different mechanisms.

But in every case, the drug enters the system that was already there. But the brain does not remain unchanged when these signals occur repeatedly. It tries to restore balance. That adaptation can contribute to tolerance.

The body may begin expecting the substance, creating physical dependence. Withdrawal may appear when the adapted systems no longer receives it. And for some people, substance use can become increasingly difficult to control despite serious harm. That larger pattern is substance use disorder.

Not every person who uses a psychoactive substance develops a disorder. Not every person with tolerance or dependence has an addiction. Risk emerges through the interaction of biology, learning, development, mental health, social experience, environment, and the substance itself. And because these factors can change, treatment and recovery are possible.

SAMHSA describes recovery as a personal process supported through multiple pathways, which may include clinical care, medication, counseling, peer support, family support, and changes in a person's environment. If this lesson helped you understand the brain rather than simply memorizing a list of drugs, hit the like button and subscribe to the Psychology Notebook so you don't miss the next lesson. And don't forget to check out thepsychologynotebook.com where you can download your free psychology notebook featuring 25 free flashcards and a bunch of study resources today. If you want a crash course on human development and discover what psychology says from conception all the way to old age, be sure to check out this video right here.